Lorus Therapeutics Inc. (LRP) Signs Research and License Option Agreement With Elanco
4/17/2013 11:25:00 AM
More...
|
Lorus Therapeutics Inc. (LRP) Presents Positive Data for Lead Anticancer Drug LOR-253
4/3/2012 7:16:23 AM
More...
|
Lorus Therapeutics Inc. (LRP) Announces Positive Results from Its Small Molecule Antimicrobial Program
3/27/2012 7:17:47 AM
More...
|
Lorus Therapeutics Inc. (LRP) Reports Second Quarter Results for Fiscal Year 2011
1/14/2011 6:46:11 AM
More...
|
Lorus Therapeutics Inc. (LRP) Enrolls First Patient in Phase I Clinical Study of Anticancer Drug LOR-253
1/13/2011 9:46:19 AM
More...
|
Lorus Therapeutics Inc. (LRP) Closes Private Placement for Gross Proceeds of $1.66 Million
12/1/2010 11:50:38 AM
More...
|
Lorus Therapeutics Inc. (LRP) Completes Rights Offering, Raising $4.6 Million
11/10/2010 6:58:42 AM
More...
|
Lorus Therapeutics Inc. (LRP) Announces Allowance of United States Patent for Lead Antimicrobial Small Molecule
10/21/2010 9:26:45 AM
More...
|
Lorus Therapeutics Inc. (LRP) Reports First Quarter Results for Fiscal Year 2011
10/15/2010 8:58:07 AM
More...
|
Lorus Therapeutics Inc. (LRP) Files Final Prospectus for Rights Offering to Shareholders
9/29/2010 9:37:43 AM
More...
|
|